Search Results

Cedars-Sinai Cancer Cedars-Sinai Cancer researchers have found that the incidence of pancreatic cancer—which historically has been higher in men than in women—increased among both men and women during the last decade, with a significantly greater relative increase observed in younger women. Read More

Sidney Kimmel Cancer Center at Jefferson Health Yuri Sykulev, MD, PhD, and colleagues at Sidney Kimmel Cancer Center at Jefferson Health, have shown that to efficiently kill melanoma cells, CAR T cells require an abundance of antigens—cancer-associated molecules that are overexpressed—on target cells. Read More

Roswell Park Comprehensive Cancer Center A number of veteran nursing team members have been promoted to new leadership roles, including a newly named deputy chief nursing officer and supervisors overseeing key clinical programs. Read More

With continued health concerns and restrictions caused by the coronavirus pandemic, the 2021 AACI/CCAF Annual Meeting was held virtually in October. More than 500 cancer center members and other colleagues participated in the three-day event. Presentations covered a wide range of topics including telehealth; COVID-19’s impact on cancer centers; computational oncology; cancer care across the lifespan; research at basic science cancer centers; and adapting clinical trials to patients’ changing ne…

University of Illinois Cancer Center University of Illinois Cancer Center researchers identified three practice recommendations for nurses to effectively reduce breast and cervical cancer disparities for women in rural communities, where residents are more likely to be diagnosed with later-stage disease and face complex barriers to high-quality cancer care. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Researchers at the UAMS Winthrop P. Rockefeller Cancer Institute and the Mayo Clinic have discovered a way to supercharge molecular cancer treatments to destroy more cancer-causing proteins in cells. Read More

The University of Texas MD Anderson Cancer Center In a first-in-human, Phase I trial, researchers at The University of Texas MD Anderson Cancer Center discovered that ATR inhibitor RP-3500 was safe and well tolerated with promising clinical benefit. Read More

Livestrong Cancer Institutes, The University of Texas at Austin, Dell Medical School "The CaLM Model: Hardwiring Cancer Centers for Whole Person Care," an initiative of Livestrong Cancer Institutes of Dell Medical School at The University of Texas at Austin, is a Silver Winner in CAPC’s second Tipping Point Challenge, an innovation and quality improvement challenge from the Center to Advance Palliative Care (CAPC) and The John A. Hartford Foundation. Read More

The 13th Annual AACI CRI Meeting Abstracts and Posters Book is now available to AACI members. The digital book features 62 abstracts from 27 cancer centers submitted for virtual presentation at the CRI meeting this past July. This year’s submissions covered topics in several categories, including Clinical Trial Operations; Investigator-Initiated Trials; Training, Quality Assurance, Remote Monitoring, and Auditing; and Trial Recruitment & Community Outreach and Engagement. Read More

The Tisch Cancer Institute at Mount Sinai Mount Sinai researchers have developed a therapy that shows promise against a deadly pediatric leukemia. The small-molecule therapy was highly effective in fighting a type of acute myeloid leukemia in both in vitro and in vivo experiments, according to recently published research. Read More

University of Illinois Cancer Center University of Illinois Cancer Center program leader Lisa Tussing-Humphreys, PhD, MS, RD, received a $3 million National Cancer Institute grant to investigate the effects of time-restricted eating versus daily continuous calorie restriction on body weight and colorectal cancer risk markers among adults with obesity. Read More

Improves Adherence & Outcomes 93% of patients surveyed report Patient Resource Guides assist them in following their physician’s treatment plan. "I felt more in control with the aid of the guide." - Breast Cancer Patient For more information, contact Amy Galey.  Learn More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A new study shows that chronic physiologic "wear and tear" from stress, known as allostatic load, may be associated with a decreased likelihood of cancer treatment completion and with lower overall survival. Read More

Rutgers Cancer Institute of New Jersey Findings from a recent population-based cohort study show that Black women diagnosed with breast cancer who also have central obesity, which means excess body fat in the abdominal area, were more likely to die from breast cancer or any other cause than similar women who didn’t have central obesity. Read More

Vanderbilt-Ingram Cancer Center The National Cancer Institute has funded a project led by Vanderbilt-Ingram Cancer Center to assess the impact of environmental exposures on cancer risk for people living in Southern states. Wei Zheng, MD, PHD, MPH, is the principal investigator of the Southern Environmental Health Study, which has received $2.4 million for the first two years of research. Read More

Fox Chase Cancer Center, Temple Health Hossein Borghaei, DO, MS, chief of the Division of Thoracic Medical Oncology at Fox Chase Cancer Center, has been named one of three winners of the second annual Lung Cancer Heroes awards program. Read More

Stanford Cancer Institute Women newly diagnosed with breast or ovarian cancer who are also carriers of cancer-associated mutations like BRCA1 or BRCA2 are no more likely to die of their tumors than those who don’t have the mutations, according to a new study. Read More

UK Markey Cancer Center A recent University of Kentucky College of Medicine study found that young adults from vulnerable communities are more likely to be exposed to tobacco marketing in their daily lives than are young adults outside these communities. The study’s findings may help community leaders create policies that reduce exposure to tobacco marketing. Read More

Roswell Park Comprehensive Cancer Center New research from Roswell Park Comprehensive Cancer Center has uncovered genetic factors other than human leukocyte antigen compatibility that significantly contribute to outcomes following blood and marrow transplant in cancer patients. Read More

University of Michigan Rogel Cancer Center A single common genetic mutation may hold the key to making immunotherapy more effective against gliomas, according to new mouse model findings from the University of Michigan Rogel Cancer Center. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Brian Koss, PhD, a researcher with the UAMS Winthrop P. Rockefeller Cancer Institute, is a recipient of the National Institutes of Health (NIH) Director’s Early Independence Award. He will receive a five-year, nearly $1.9 million grant to fund his highly specialized cancer research at UAMS. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center’s Edna "Eti" Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been named a senior editor for Cancer Research Communications, a new online journal. Read More

University of Florida Health Cancer Center University of Florida Health researcher Naykky Singh Ospina, MD, is leading a team developing a conversation aid to be used during what can be a challenging clinical encounter when it’s crucial for a doctor to clearly and completely communicate a patient’s cancer risk and management options. Read More

Siteman Cancer Center Washington University researchers at Siteman Cancer Center have surveyed cancer doctors to identify differences in physician attitudes and beliefs that may contribute to a gap in referrals to genetic counseling and testing between Black women and white women with breast cancer. Foluso O. Ademuyiwa, MD, MPH, MSCI, is first author on the study. Read More

University of Virginia Cancer Center Jamie Zoellner, PhD, RD, has assumed the role of co-lead of the Cancer Prevention and Population Health (CPH) program. She will work with Li Li, MD, PhD, who is continuing his role as CPH co-leader. Read More

Sidney Kimmel Cancer Center at Jefferson Health Sidney Kimmel Cancer Center at Jefferson Health (SKCC) welcomes Marcia Brose, MD, PhD, as vice chair of medical oncology and SKCC regional chief of cancer services at Jefferson Torresdale Hospital in Northeast Philadelphia. Read More

Huntsman Cancer Institute at the University of Utah Matthew Poppe, MD, physician-scientist at Huntsman Cancer Institute, received a grant from the National Cancer Institute to advance his research in the treatment of pediatric cancers using different types of radiation therapy: proton therapy and photon therapy. Read More

Rutgers Cancer Institute of New Jersey A recent consensus statement from the Particle Therapy Cooperative Group Breast Cancer Subcommittee assessed data on proton therapy for breast cancer, providing expert consensus recommendations on indications and technique, and highlighting ongoing clinical trials cost-effectiveness analyses and key areas for future research. Read More

VCU Massey Comprehensive Cancer Center Walter Lawrence, Jr., MD, who died in November at age 96, was respected and beloved for his expertise as a surgical oncologist. He ran a surgical hospital during the Korean War, oversaw the first Division of Surgical Oncology at VCU, and served as the inaugural director of VCU Massey Cancer Center for more than a decade. Read More

AACI cancer center directors are invited to submit nominations for the 2022 Champion for Cures Award. AACI established the award in 2018 to recognize an individual or individuals who, through direct financial support of an AACI cancer center, demonstrate exceptional leadership in advancing cancer research and care and in inspiring others to do the same. The 2021 Champion for Cures Award was presented virtually at the AACI/CCAF Annual Meeting to Sidney and Caroline Kimmel (pictured). Read More

Sylvester Comprehensive Cancer Center, University of Miami Recognizing Sylvester Comprehensive Cancer Center’s enduring commitment to addressing the inequities that perpetuate cervical cancer in South Florida and beyond, the World Health Organization (WHO) has designated the University of Miami institution as the first WHO Collaborating Centre for Cervical Cancer Elimination. Read More

The University of Kansas Cancer Center Women living in rural areas are less likely to follow the recommended screenings for colorectal cancer. However, they are just as likely as women living in urban areas to receive mammograms, researchers have found. Nearly 3,000 women participated in the cross-sectional study. Babalola Faseru, MBChB, MPH, is principal investigator. Read More

On Wednesday, November 30, the United States House of Representatives passed the PREVENT HPV Cancers Act by voice vote. The bill, lead sponsored by Representatives Kathy Castor (D-FL) and Kim Schrier (D-WA), was introduced in early March in coordination with International HPV Awareness Day. AACI was an early supporter of the bill.   Read More

UK Markey Cancer Center A new training program at the University of Kentucky will help develop the next generation of scientists. Funded by a grant from the National Cancer Institute, Addressing Rural cancer Inequities through Scientific Excellence (ARISE) is focused on preparing postdoctoral researchers to address cancer-related health disparities. Read More

University of Virginia Cancer Center Hao Jiang, PhD, and his collaborators have revealed why a mutation in the UTX gene disrupts cells’ ability to suppress tumors. The gene product, they found, forms tiny droplets in cells that help prevent tumor formation. But the mutation throws a wrench in that important process, leaving affected people vulnerable. Read More

University of Virginia Cancer Center The University of Virginia Cancer Center and Cancer Center Without Walls Southwest Virginia Community Advisory Board has launched a program to cut tobacco use among both teens and adults in partnership with UVA Wise students and Virginia Cooperative Extension. Read More

Roswell Park Comprehensive Cancer Center Following a national search, Roswell Park Comprehensive Cancer Center has promoted Emese Zsiros, MD, PhD, FACOG, to lead its Department of Gynecologic Oncology. On staff at Roswell Park since 2014, Dr. Zsiros will also hold the Shashikant B. Lele, MD, Endowed Chair in Gynecologic Oncology. Read More

Duke Cancer Institute, Duke University Medical Center Duke Cancer Institute member and director of the Duke Center for Applied Genomics and Precision Medicine Geoffrey Ginsburg, MD, PhD, will leave Duke to assume the role of Chief Medical and Scientific Officer for the National Institutes of Health "All of Us" Research Program, effective January 2022. Read More

University of Michigan Rogel Cancer Center A new study from University of Michigan School of Public Health and Rogel Cancer Center will describe and quantify the impact of known and suspected environmental exposures on cancer risk. The program, called MI-CARES, or Michigan Cancer and Research on the Environment Study, is funded through a $13 million grant from the National Cancer Institute. Read More

Siteman Cancer Center Washington University researchers at Siteman Cancer Center have received a $17 million Cancer Moonshot grant to address disparities in cancer research, treatment, and outcomes in underrepresented populations. Read More

"These guides build bi-directional communication between our providers and their patients. We’ve seen an increase in patient retention and overall patient satisfaction." - Terry T. Tsue, MD, FACS, Vice President and Physician-in-Chief, The University of Kansas Cancer Center; Vice President of Physician Services, The University of Kansas Health System    For more information, contact Amy Galey.    Learn More

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program which provides home infusion cancer treatments for eligible patients. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center D. Wade Clapp, MD, is leading an $11.4 million grant from the National Cancer Institute in which he and others across the country will work on identifying new treatments for tumors that develop in children, adolescents, and adults with a common genetic condition. Read More

The Clinical Research Services (CRS) department in the Sylvester Comprehensive Cancer Center is expanding and is currently hiring for multiple Clinical Research, Regulatory, and Research Nurse positions at all levels. To be considered for the openings, submit your application to job no. R100044788. Learn More

Stanford Cancer Institute Researchers at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have devised a tool to examine how cells behave and interact in various environments of the body. They’ve used it to better understand how cancer develops and can be treated. Read More

Moffitt Cancer Center Researchers at Moffitt Cancer Center are trying to improve the personalization of radiation therapy through computer modeling. In a new study, they model how interactions between cancer cells and immune cells, and their subsequent responses to radiation, impact the tumor. Read More

Fred Hutchinson Cancer Center Fred Hutchinson Cancer Research Center neuroscientist Eric Holland, MD, PhD, has received a National Cancer Institute Outstanding Investigator Award. The seven-year, $7 million grant will support Holland’s investigations into different classes of genetic mutations and how they can cause cancer. Read More

University of Illinois Cancer Center Nurse Practitioner Mary Pasquinelli, MS, APRN, of the UI Health Lung Screening Program, received a national leadership award from the Prevent Cancer Foundation for her work building and growing the highly effective program that benefits medically underserved communities and her research on lung cancer health disparities. Read More

Montefiore Einstein Comprehensive Cancer Center In 2015, Julio Aguirre-Ghiso, PhD, and his team identified the receptor NR2F1, present in the nuclei of tumor cells, as a master regulator of tumor cell dormancy. Now, in a new study, he and his colleagues have discovered a compound that activates this nuclear receptor and have shown it can cause tumor-cell dormancy in cancer cell lines and in a patient-derived mouse model of metastatic cancer. Read More

Vanderbilt-Ingram Cancer Center In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer that appears to be able to escape detection by the immune system and evade immunotherapy. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for inoperable pleural mesothelioma, according to a Phase II clinical trial led by the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Read More

The Tisch Cancer Institute at Mount Sinai Mount Sinai Kravis Children’s Hospital has appointed Oren J. Becher, MD, as the chief of the Jack Martin Division of Pediatric Hematology-Oncology. A physician-scientist, Dr. Becher is an expert in brain tumors in children, particularly diffuse intrinsic pontine glioma. Read More

Siteman Cancer Center Sam Bhayani, MD, a Washington University urologic oncologist and researcher at Siteman Cancer Center, has been named head of the Division of Urologic Surgery at Washington University School of Medicine in St. Louis. A leader in robotic surgery, Dr. Bhayani helped to develop innovative surgical techniques for removing prostate and kidney cancers. Read More

Huntsman Cancer Institute at the University of Utah Younger B-cell non-Hodgkin lymphoma survivors (B-HNL) had a higher relative risk of developing age-related diseases than older B-NHL survivors five years or more after cancer diagnosis, according to recently published results. Read More

UK Markey Cancer Center A recent study shows that patients with non-small cell lung cancer reviewed by the UK Markey Cancer Center’s Molecular Tumor Board experience improved outcomes, even if they reside in rural Appalachian Kentucky. Read More

WVU Cancer Institute Mark McLaughlin, PhD—a researcher with the WVU Cancer Institute and Modulation Therapeutics Inc.—and his colleagues are developing a cancer treatment that zeroes in on the diseased cells with more precision. Based on extensive preclinical research, they have received approval from the U.S. Food and Drug Administration to begin human trials of a new drug to treat eye cancer. Read More

City of Hope Comprehensive Cancer Center City of Hope has opened of a first-in-human clinical trial evaluating the use of a cancer-killing oncolytic virus to treat patients with metastatic triple-negative breast cancer. The study is designed to determine the safety and optimal biological dose that may induce an immune response in triple-negative breast cancer tumors. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine A study led by researchers at Baylor College of Medicine can help scientists make reasonable predictions of what genomic changes may happen in advanced cancer depending on the therapy received, how these changes may affect cancer progression and the possibility of preventing or minimizing outcomes with treatments. Read More

Stanford Cancer Institute Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in laboratory mice after it’s injected into their bloodstreams. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Leptin, a molecule produced by fat cells, appears to cancel out the effects of the estrogen-blocking therapy tamoxifen, a drug commonly used to treat and prevent breast cancers, suggests a new study led by researchers from the Johns Hopkins Kimmel Cancer Center. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Ruth “Rikki” Kutcher Goldstein has made a $2 million gift to support cancer research at Indiana University School of Medicine. The Rikki and Leonard Goldstein Chair in Cancer Research will be held by a lung or pancreatic cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Read More

Yale Cancer Center, Yale School of Medicine For years much about anaplastic lymphoma kinase—its role in the body, which molecules interact with it, what it looks like—has remained unknown, limiting efforts to target it for treatment. Now, two studies led by Yale Cancer Center reveal the structure of this molecule, opening new paths for cancer treatment development. Read More

USC Norris Comprehensive Cancer Center To correlate gene expression signatures with cancer progression and chemotherapy resistance, a team of scientists led by Rong Lu, PhD, from USC and Akil A. Merchant, MD, from Cedars-Sinai have introduced a new genetic technology in a recently published study. Read More

Georgetown Lombardi Comprehensive Cancer Center More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment with targeted therapies. The finding comes from a clinical trial that was stopped early because definitive results became apparent sooner than expected. Read More

VCU Massey Comprehensive Cancer Center Virginia Commonwealth University Massey Cancer Center and Virginia State University have received a "team science” grant from the National Cancer Institute focused on reducing cancer disparities and providing hands-on research opportunities to students who are historically underrepresented in science. The total award amount is $1.7 million over the course of four years. Read More

University of Michigan Rogel Cancer Center Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20 percent among the high-risk patients. Read More

Huntsman Cancer Institute at the University of Utah In a new study, researchers from Huntsman Cancer Institute and the University of California San Francisco explain how common moles and melanomas form and why moles can change into melanoma. The study shows melanocytes that turn into melanoma do not need to have additional mutations but are actually affected by environmental signaling, when cells receive signals from the environment in the skin around them that give them direction. …

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Bridget Oppong, MD, has been appointed deputy director of the Center for Cancer Health Equity at OSUCCC – James. Dr. Oppong’s research focuses on health disparities that lead to poorer outcomes and higher mortality rates among patients with breast cancer. Read More

Duke Cancer Institute, Duke University Medical Center Duke Cancer Institute member Hayley Moss, MD, MBA, has joined the U.S. Department of Veterans Affairs' National Oncology Program Office as director of the Breast and Gynecologic Cancer System of Excellence, a new initiative that aims to advance and expand women veterans' access to tele-oncology and potentially lifesaving clinical trials and treatments. Read More

UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center has appointed Wendy Brewster, MD, PhD, as associate director of diversity, equity, and inclusion. The newly created position underscores the cancer center’s commitment to developing a more inclusive workplace. Read More

Vanderbilt-Ingram Cancer Center Sonya Reid, MD, MPH, is a recipient of an NRG Oncology Underserved Minority Scholars Award. She is one of three inaugural recipients of the award, which was established by NRG Oncology this year to address cancer equity by intensively training early-stage investigators about clinical trials through the National Cancer Institute Community Oncology Research Program (NCORP). Read More

UCLA Jonsson Comprehensive Cancer Center Like locking the door but opening windows, an immune checkpoint therapy temporarily slows glioblastoma progression but fails to establish an effective anti-tumor microenvironment and appears to increase molecular interactions inhibiting long-term immune response, according to studies led by a UCLA research team. Read More

Wilmot Cancer Institute, UR Medicine Doctors can safely lower the dose of cancer treatment such as chemotherapy without impacting survival for adults older than 70 who are at high risk for toxic side effects. The results are from a potentially practice-changing new study led by a Wilmot Cancer Institute scientist at the University of Rochester Medical Center. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise program after their operation, according to a new study. Read More

UMMC Cancer Center and Research Institute Thy Huynh, MD, has joined the University of Mississippi Medical Center as an assistant professor of dermatology and pediatrics. She will be a member of the Cancer Center and Research Institute Interdisciplinary Skin Cancer Team and will conduct research in this field. Read More

Fox Chase Cancer Center, Temple Health In Vino Vita, Fox Chase Cancer Center’s signature fundraising event, was held on October 30 at the National Constitution Center, and raised over $1.5 million for cancer research, treatment, and prevention. Read More

Roswell Park Comprehensive Cancer Center In acknowledgment of strong advocacy for its staff members and the launch of a program to enhance their mental health and well-being, Roswell Park Comprehensive Cancer Center has been named a 2021 Joy in Medicine Recognized Organization by the American Medical Association. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center has been recognized for excellence in patient care with two Press Ganey Awards, the Pinnacle of Excellence Award and the Guardian of Excellence Award. Press Ganey works to support health care organizations by providing important assistance with health care challenges. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The Bristol Myers Squibb Foundation, along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences neurosurgeon Analiz Rodriguez, MD, PhD, to participate in its Diversity in Clinical Trials Career Development Program. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone NYU Langone Health’s Laura and Isaac Perlmutter Cancer Center opened a new state-of-the-art center to treat people with blood cancers, including leukemia, lymphoma, and multiple myeloma. The new Transplantation and Cellular Therapy Center is part of the Blood and Marrow Transplant Program and the larger Center for Blood Cancers at Perlmutter Cancer Center, supported by an anonymous $75 million gift. Read More

Stanford Cancer Institute Steven Coutre, MD, a professor of hematology at the Stanford School of Medicine, died November 9 in Palo Alto, California, from complications of leukemia and COVID-19. He was 62. The director of Stanford Health Care’s hematology clinic, Coutre had a passion for rigorous science and was integral to the development of new therapies for blood disorders. Read More

Yale Cancer Center, Yale School of Medicine Several Yale Cancer Center faculty have authored chapters in a newly released book, A New Deal For Cancer: Lessons from a 50 Year War. In recognition of the 50th anniversary of the landmark signing of the National Cancer Act, the book reflects on the decades-long battle to eradicate the hundreds of complex diseases that fall within the umbrella of cancer. Read More

Duke Cancer Institute, Duke University Medical Center A new open-access book written by experts in the field of oncology, hematology, and stem cell transplantation—The Comprehensive Cancer Center—is now available for download. Read More

The Tisch Cancer Institute at Mount Sinai Jose Javier Bravo-Cordero, PhD, and colleagues have reported on their findings that show how cancer cells remain dormant for years after they leave a tumor and travel to other parts of the body, before awakening to create metastatic cancer. Read More

Huntsman Cancer Institute at the University of Utah Theresa L. Werner, MD, has been appointed to the position of senior director of clinical research. She has served as clinical trials office medical director since 2015, was a recipient of a National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award in 2016, and recently finished her three-year term as the chair of AACI's Clinical Research Innovation (CRI) steering committee. Read More

Fred Hutchinson Cancer Center The Fred Hutch/University of Washington Cancer Consortium has named Christopher Li, MD, PhD, its first associate director of diversity, equity and inclusion (DEI). In this role, Dr. Li will coordinate and drive work that enhances DEI efforts across the consortium’s partner institutions. Read More

University of Michigan Rogel Cancer Center University of Michigan Regent Ron Weiser has committed $30 million to Michigan Medicine to establish an innovative, patient-focused program in prostate cancer. The Ronald Weiser Center for Prostate Cancer will invest in staff, infrastructure, technologies and education as well as research into the disease and its treatment. Read More

Legorreta Cancer Center at Brown University A $25 million gift from life sciences entrepreneur and investor Pablo Legorreta and his wife, Almudena, will advance a plan to transform Brown University’s recently launched cancer center into a world-class facility. Wafik El-Deiry, MD, PhD, FACP, is the center's director. Read More

Moffitt Cancer Center With a transformational philanthropic gift of $15 million from the Richard M. Schulze Family Foundation, Moffitt Cancer Center has announced that in 2022 it will initiate its plan for a new proton therapy treatment facility. Read More

UK Markey Cancer Center Launched in the summer of 2021 with funding from the American Cancer Society, SHE in Oncology empowers Kentucky high school students who identify as female with experiences that give them insight about career interests and leadership opportunities in the field of oncology. Read More

Vanderbilt-Ingram Cancer Center Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a "supermere," which contains enzymes, proteins, and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease, and even COVID-19. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UC San Francisco has launched the Baszucki Lymphoma Therapeutics Initiative to increase the effectiveness and availability of chimeric antigen receptor T-cell (CAR T) therapy for lymphoma patients. Jan Ellison Baszucki and her husband, Roblox CEO David Baszucki, gifted $6 million over five years to support the initiative. Read More

The University of Kansas Cancer Center Socioeconomic status may be a factor when it comes to using telemedicine, researchers have observed. Among 16,000 people with a new cancer diagnosis, those with the highest socioeconomic status were more likely to use telemedicine within 30 days of diagnosis. The study was led by Ronald Chen, MD, MPH, and his team at The University of Kansas Cancer Center. Read More

Cedars-Sinai Cancer A research team co-led by Cedars-Sinai has created a method for using widely available data to identify proteins that could play key roles in tumor formation. Called master transcription factors, these proteins vary with each cancer type and could provide targets for therapies. Read More

City of Hope Comprehensive Cancer Center Researchers at City of Hope have identified a pathway that explains how mutated cancer cells can continue to replicate and become resistant to oncology therapies. Using whole genome sequencing technology, the scientists discovered a new mechanism for how genetically defective cells mutate to survive stressful situations, such as drug treatment. Read More

Wilmot Cancer Institute, UR Medicine Researchers at the University of Rochester Del Monte Institute for Neuroscience and Rochester Institute of Technology have received a U.S. patent for technology designed to accelerate development of cell therapies for cancer and other bio-therapies. The technique provides a less toxic alternative to standard gene transfer techniques by using an array of carbon nanotubes to deliver DNA into primary neurons, immune cells, and stem cells. Read …

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Johns Hopkins astrophysicist, Alexander Szalay, PhD, and Kimmel Cancer Center pathologist Janis Taube, MD, MSc, received a Life Sciences 2021 award for AstroPath at this year’s Falling Walls Science Summit, an international event honoring research breakthroughs from across the globe. Their submission, "Breaking the Wall to Mapping Cancer Using Multispectral Microscopy," was selected from hundreds of entries. Read More

Duke Cancer Institute, Duke University Medical Center Although Black lung cancer patients are more likely to die from their disease than white patients, they have better outcomes than whites when treated with immunotherapies that are now considered the best standard of care, a team of researchers led by Tomi Akinyemiju, PhD, has found. Read More